{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:41:45Z","timestamp":1788964905966,"version":"build-2803163510"},"reference-count":25,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9,1]]},"DOI":"10.1210\/jc.2013-4340","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T13:23:18Z","timestamp":1394544198000},"page":"3055-3059","source":"Crossref","is-referenced-by-count":39,"title":["Vandetanib Successfully Controls Medullary Thyroid Cancer-Related Cushing Syndrome in an Adolescent Patient"],"prefix":"10.1210","volume":"99","author":[{"given":"A. A.","family":"Nella","sequence":"first","affiliation":[{"name":"Section on Endocrinology and Genetics (A.A.N., M.B.L., C.A.S.), Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. B.","family":"Lodish","sequence":"additional","affiliation":[{"name":"Section on Endocrinology and Genetics (A.A.N., M.B.L., C.A.S.), Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fox","sequence":"additional","affiliation":[{"name":"Section on Endocrinology and Genetics (A.A.N., M.B.L., C.A.S.), Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892"},{"name":"Division of Oncology and Center for Childhood Cancer Research (E.F., F.M.B.), The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. M.","family":"Balis","sequence":"additional","affiliation":[{"name":"Pharmacology and Experimental Therapeutics Section, Pediatric Oncology Branch (E.F., F.M.B., P.O.W., J.D., B.C.W.), Bethesda, Maryland 20892"},{"name":"Division of Oncology and Center for Childhood Cancer Research (E.F., F.M.B.), The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Quezado","sequence":"additional","affiliation":[{"name":"General Surgical Pathology Section (M.M.Q.), Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. O.","family":"Whitcomb","sequence":"additional","affiliation":[{"name":"Pharmacology and Experimental Therapeutics Section, Pediatric Oncology Branch (E.F., F.M.B., P.O.W., J.D., B.C.W.), Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Derdak","sequence":"additional","affiliation":[{"name":"Pharmacology and Experimental Therapeutics Section, Pediatric Oncology Branch (E.F., F.M.B., P.O.W., J.D., B.C.W.), Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kebebew","sequence":"additional","affiliation":[{"name":"Endocrine Oncology Branch (E.K.), Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. C.","family":"Widemann","sequence":"additional","affiliation":[{"name":"Pharmacology and Experimental Therapeutics Section, Pediatric Oncology Branch (E.F., F.M.B., P.O.W., J.D., B.C.W.), Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"Stratakis","sequence":"additional","affiliation":[{"name":"Section on Endocrinology and Genetics (A.A.N., M.B.L., C.A.S.), Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113413027700_B1","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1","article-title":"A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985\u20131995 [see comments]","volume":"83","author":"Hundahl","year":"1998","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041113413027700_B2","doi-asserted-by":"crossref","DOI":"10.1159\/isbn.978-3-318-01421-1","article-title":"Diseases of the thyroid in childhood and adolescence","author":"Krassas","year":"2007"},{"key":"key\n\t\t\t\t2019041113413027700_B3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1089\/thy.2006.16.1163","article-title":"Biochemical markers in the follow-up of medullary thyroid cancer","volume":"16","author":"de Groot","year":"2006","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113413027700_B4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1089\/thy.2005.15.618","article-title":"Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature","volume":"15","author":"Barbosa","year":"2005","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113413027700_B5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMc1301428","article-title":"Reversal of Cushing's syndrome by vandetanib in medullary thyroid carcinoma","volume":"369","author":"Baudry","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113413027700_B6","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1210\/jc.2010-2276","article-title":"Ectopic ACTH syndrome in children and adolescents","volume":"96","author":"More","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113413027700_B7","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1158\/1078-0432.CCR-13-0071","article-title":"Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma","volume":"19","author":"Fox","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t2019041113413027700_B8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t2019041113413027700_B9","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1200\/JCO.2012.48.4659","article-title":"Cabozantinib in progressive medullary thyroid cancer","volume":"31","author":"Elisei","year":"2013","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041113413027700_B10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archinte.1986.00360170151022","article-title":"Occult ectopic secretion of corticotropin","volume":"146","author":"Findling","year":"1986","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113413027700_B11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1148\/radiology.172.1.2544919","article-title":"Ectopic adrenocorticotropic hormone syndrome: localization studies in 28 patients","volume":"172","author":"Doppman","year":"1989","journal-title":"Radiology"},{"key":"key\n\t\t\t\t2019041113413027700_B12","first-page":"4645","article-title":"ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration","volume":"62","author":"Wedge","year":"2002","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041113413027700_B13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0195-6663(91)90068-4","article-title":"Is the effect of a social model on eating attenuated by hunger?","volume":"17","author":"Goldman","year":"1991","journal-title":"Appetite"},{"key":"key\n\t\t\t\t2019041113413027700_B14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/jc.2012-4085","article-title":"Clinical review: kinase inhibitors: adverse effects related to the endocrine system","volume":"98","author":"Lodish","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113413027700_B15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib malate for the treatment of pancreatic neuroendocrine tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113413027700_B16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MPA.0b013e31825c53fa","article-title":"Sunitinib for the treatment of metastatic paraganglioma and vasoactive intestinal polypeptide-producing tumor (VIPoma)","volume":"42","author":"Bourcier","year":"2013","journal-title":"Pancreas"},{"key":"key\n\t\t\t\t2019041113413027700_B17","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1210\/jc.2012-2356","article-title":"Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas","volume":"97","author":"Ayala-Ramirez","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113413027700_B18","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.ejca.2013.06.042","article-title":"Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: a phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801)","volume":"49","author":"Castellano","year":"2013","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t2019041113413027700_B19","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1172\/JCI60417","article-title":"EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas","volume":"121","author":"Fukuoka","year":"2011","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113413027700_B20","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1038\/sj.onc.1207810","article-title":"Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors","volume":"23","author":"Carlomagno","year":"2004","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t2019041113413027700_B21","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1634\/theoncologist.2011-0148","article-title":"Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors","volume":"16","author":"Glade Bender","year":"2011","journal-title":"Oncologist"},{"key":"key\n\t\t\t\t2019041113413027700_B22","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1089\/thy.2013.0137","article-title":"In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer","volume":"23","author":"Bentzien","year":"2013","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113413027700_B23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12020-013-9946-6","article-title":"Metabolic response demonstrated by 18F-FDG-PET\/CT in metastatic medullary thyroid carcinoma under sorafenib therapy","volume":"44","author":"Mart\u00ednez-Rodr\u00edguez","year":"2013","journal-title":"Endocrine"},{"key":"key\n\t\t\t\t2019041113413027700_B24","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1158\/1078-0432.CCR-10-0994","article-title":"Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation","volume":"16","author":"Carr","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t2019041113413027700_B25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1586\/14737140.8.4.625","article-title":"RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer","volume":"8","author":"Lodish","year":"2008","journal-title":"Expert Rev Anticancer Ther"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/9\/3055\/9048511\/jcem3055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T06:59:20Z","timestamp":1565247560000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/9\/3055\/2537757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,1]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-4340","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,1]]}}}